Zilucoplan: A Newly Approved Macrocyclic Peptide for Treatment of Anti-Acetylcholine Receptor Positive Myasthenia Gravis
Article in Drugs and Drug Candidates (March 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives
Article in Drug Design Development and Therapy (September 2023)
Dry powder formulation of azithromycin for COVID-19 therapeutics
Article in Journal of Microencapsulation (March 2023)